US Broker Ratings

Natera, Inc. (NTRA) Stock Analysis: Why this Diagnostics Leader Offers a Potential 31.56% Upside

Natera, Inc. (NASDAQ: NTRA) stands out in the healthcare sector as a robust player in the diagnostics and research industry. With a market capitalization of $28.08 billion, the company has..

Genmab A/S (GMAB) Stock Analysis: Exploring a 39% Potential Upside for Biotechnology Investors

As a pioneering force in the biotechnology sector, Genmab A/S (GMAB) stands out not only for its innovative antibody-based therapies but also for its compelling investment prospects. Based in Denmark,..

Corcept Therapeutics (CORT) Investor Outlook: Unpacking the 93% Potential Upside

Corcept Therapeutics Incorporated (CORT), a biopharmaceutical company based in Redwood City, California, is capturing investor attention with a compelling story of innovation and potential growth within the healthcare sector. Known..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant with a Robust Growth Trajectory

As one of the stalwarts in the healthcare sector, McKesson Corporation (NYSE: MCK) continues to stand out in the medical distribution industry. With a market capitalization of $113.46 billion, McKesson..

Neurocrine Biosciences, Inc. (NBIX) Investor Outlook: Exploring a 38% Potential Upside Amid Strong Revenue Growth

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector, continues to draw investor attention with its compelling financial metrics and robust product pipeline. Specializing in the discovery..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 25.76% Potential Upside

Globus Medical, Inc. (NYSE: GMED), a leading player in the healthcare sector, particularly within the medical devices industry, continues to capture investor attention with its innovative solutions for musculoskeletal disorders...

Amgen Inc. (AMGN) Stock Analysis: Evaluating a Solid Player in the Healthcare Sector with Robust Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, has long been a reliable choice for investors seeking exposure to the pharmaceutical industry. With a market capitalization of $199.2..

Becton, Dickinson and Company (BDX) Stock Analysis: A 17.97% Potential Upside Beckons Investors

Becton, Dickinson and Company (NYSE: BDX), a venerable player in the healthcare sector, is garnering attention from investors thanks to its robust market presence and a potential upside of 17.97%...

Tempus AI, Inc. (TEM) Investor Outlook: Exploring a 48% Potential Upside in Healthcare Tech

Tempus AI, Inc. (NASDAQ: TEM) has emerged as a significant player in the healthcare technology sector, operating at the intersection of artificial intelligence and healthcare services. The company’s innovative approach,..

Charles River Laboratories Inte (CRL) Stock Analysis: Navigating Potential 13% Upside with Strong Buy Ratings

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $8.59 billion,..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 12.73% Upside Potential in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a key player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of $11.14 billion,..

Labcorp Holdings Inc. (LH) Stock Analysis: A Diagnostic Leader with a 14% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, particularly in diagnostics and research, stands out with a market capitalization of $22.36 billion. Headquartered in Burlington, North..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 30% Upside Potential

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, is gaining attention from investors due to its strong growth metrics and potential upside. As a company..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 41% Potential Upside

argenx SE (NASDAQ: ARGX) stands as a formidable entity within the biotechnology sector, capturing the interest of investors with its innovative approach to treating autoimmune diseases. Founded in 2008 and..

The Ensign Group, Inc. (ENSG) Stock Analysis: Strong Revenue Growth and a 6.36% Upside Potential

For investors seeking opportunities in the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) offers a compelling prospect. With a market capitalization of $12.04 billion, Ensign operates primarily in the..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with 30.90% Potential Upside

Revvity, Inc. (NASDAQ: RVTY), formerly known as PerkinElmer, Inc., has been making significant strides in the healthcare sector since its inception in 1937. With its recent rebranding and strategic focus..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: An In-Depth Look at Investor Ratings and Valuation Insights

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, captures investor attention with its strategic position in the drug manufacturing industry, particularly in specialty and generic..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 29.9% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Solventum Corporation (SOLV) an intriguing prospect. With a market capitalization of $12.04 billion, Solventum operates in the Medical Instruments & Supplies..

Doximity, Inc. (DOCS) Investor Outlook: Assessing a 57.67% Potential Upside in Healthcare’s Digital Revolution

Doximity, Inc. (NYSE: DOCS) stands as a leading digital platform tailor-made for healthcare professionals in the United States, providing a comprehensive suite of digital tools that enhance medical collaboration and..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 23.70% Potential Upside Amidst Healthcare Evolution

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, continues to captivate investor interest with its robust market presence and strategic evolution in health solutions. Headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds